Published in PLoS Pathog on May 14, 2015
Impact of the Pla Protease Substrate α2-Antiplasmin on the Progression of Primary Pneumonic Plague. Infect Immun (2015) 0.81
Spatially Distinct Neutrophil Responses within the Inflammatory Lesions of Pneumonic Plague. MBio (2015) 0.80
Yersinia versus host immunity: how a pathogen evades or triggers a protective response. Curr Opin Microbiol (2015) 0.79
Yersinia type III effectors perturb host innate immune responses. World J Biol Chem (2016) 0.77
Yersinia pestis Requires Host Rab1b for Survival in Macrophages. PLoS Pathog (2015) 0.76
Yersinia enterocolitica YopH-deficient Strain Activates Neutrophil Recruitment to Peyer's patches Promoting Clearance of the Virulent Strain. Infect Immun (2016) 0.75
A Rapid Molecular Test for Determining Yersinia pestis Susceptibility to Ciprofloxacin by the Quantification of Differentially Expressed Marker Genes. Front Microbiol (2016) 0.75
Fis Is Essential for Yersinia pseudotuberculosis Virulence and Protects against Reactive Oxygen Species Produced by Phagocytic Cells during Infection. PLoS Pathog (2016) 0.75
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene (1999) 13.46
Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol (2006) 12.29
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 7.10
Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun (1986) 6.92
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res (1996) 6.03
Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res (2007) 5.60
Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 4.71
Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol (2005) 4.46
The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol (1997) 4.38
Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science (2000) 4.22
Essential virulence determinants of different Yersinia species are carried on a common plasmid. Plasmid (1981) 4.07
Neutrophils, from marrow to microbes. Immunity (2010) 3.97
Acute lower respiratory tract infection. N Engl J Med (2008) 3.70
Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun (1993) 3.38
Yersinia type III secretion: send in the effectors. J Cell Biol (2002) 3.04
Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci U S A (2005) 3.01
The neutrophil in vascular inflammation. Nat Med (2011) 2.84
YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol (1998) 2.83
A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science (2007) 2.69
Expression and biologic characterization of the murine chemokine KC. J Immunol (1995) 2.66
CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun (2000) 2.66
A rapid and simple method for inactivating chromosomal genes in Yersinia. FEMS Immunol Med Microbiol (2003) 2.54
Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol (2011) 2.38
Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci U S A (2006) 2.25
The bacterial injection kit: type III secretion systems. Ann Med (2005) 2.23
Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol (2007) 2.15
Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev (2007) 2.14
Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med (2013) 2.13
Resistance of Yersinia pestis to antimicrobial agents. Antimicrob Agents Chemother (2006) 1.97
Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun (2001) 1.88
Neutrophil recruitment to the lungs during bacterial pneumonia. Infect Immun (2008) 1.87
Neutrophil mobilization and clearance in the bone marrow. Immunology (2008) 1.87
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med (2005) 1.85
Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis (2005) 1.73
Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med (1994) 1.72
Emerging mechanisms of neutrophil recruitment across endothelium. Trends Immunol (2011) 1.65
Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun (2007) 1.64
Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol (1992) 1.60
Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun (2006) 1.59
G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors (2005) 1.57
Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr Opin Microbiol (2005) 1.57
Yersinia outer proteins: Yops. Cell Microbiol (2007) 1.52
Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis. Mol Microbiol (2003) 1.34
Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology (2008) 1.28
Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates. Infect Immun (2004) 1.26
V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microb Pathog (1998) 1.24
Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun (2006) 1.23
Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation. Proc Natl Acad Sci U S A (2012) 1.22
YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T-cell proliferation through inactivation of the phosphatidylinositol 3-kinase pathway. Mol Microbiol (2002) 1.19
Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun (2006) 1.17
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. J Clin Invest (2009) 1.16
Interleukin-1-mediated stabilization of mouse KC mRNA depends on sequences in both 5'- and 3'-untranslated regions. J Biol Chem (2000) 1.14
Effect of low- and high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells. Infect Immun (2002) 1.13
Yersinia pestis subverts the dermal neutrophil response in a mouse model of bubonic plague. MBio (2013) 1.09
Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague. PLoS One (2009) 1.07
Early host cell targets of Yersinia pestis during primary pneumonic plague. PLoS Pathog (2013) 1.04
Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun (2008) 1.03
Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection. Cell Microbiol (2006) 1.03
Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors. Cell Microbiol (2013) 1.02
The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PLoS One (2009) 1.01
Endothelial heterogeneity and adhesion molecules N-glycosylation: implications in leukocyte trafficking in inflammation. Glycobiology (2013) 0.99
Neutrophils are important in early control of lung infection by Yersinia pestis. Microbes Infect (2010) 0.99
The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammation. Cell Host Microbe (2014) 0.98
Neutrophils launch monocyte extravasation by release of granule proteins. Thromb Haemost (2009) 0.98
Early interaction of Yersinia pestis with APCs in the lung. J Immunol (2005) 0.98
Direct and alternative antimicrobial mechanisms of neutrophil-derived granule proteins. J Mol Med (Berl) (2009) 0.94
NF-kappaB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation. BMC Immunol (2004) 0.94
Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis. Methods Mol Biol (2011) 0.93
YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia. BMC Immunol (2010) 0.91
IL-17A produced by neutrophils protects against pneumonic plague through orchestrating IFN-γ-activated macrophage programming. J Immunol (2013) 0.85
Plague studies. IX. Epidemiology. Bull World Health Organ (1953) 0.85
Disparity between Yersinia pestis and Yersinia enterocolitica O:8 in YopJ/YopP-dependent functions. Adv Exp Med Biol (2007) 0.84
Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells. Respir Physiol Neurobiol (2004) 0.84
Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague. Am J Pathol (2011) 0.83
Immunomodulation of macrophages by pathogenic Yersinia species. Arch Immunol Ther Exp (Warsz) (2002) 0.83
Early sensing of Yersinia pestis airway infection by bone marrow cells. Front Cell Infect Microbiol (2012) 0.80
Identification of genes involved in Yersinia pestis virulence by signature-tagged mutagenesis. Adv Exp Med Biol (2003) 0.78